Patents by Inventor David P. Basile

David P. Basile has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20240103840
    Abstract: Embodiments described herein provide a system and method for secure delivery of assets to a trusted device. Multiple levels of verification are implemented to enable components of a software update and asset delivery system to verify other components within the system. Furthermore, updates are provided only to client devices that are authorized to receive such updates. In one embodiment, the specific assets provided to a client device during a software update can be tailored to the client device, such that individual client devices can receive updated versions of software asset at a faster or slower rate than mass market devices. For example, developer or beta tester devices can receive pre-release assets, while enterprise devices can receive updates at a slower rate relative to mass market devices.
    Type: Application
    Filed: November 21, 2023
    Publication date: March 28, 2024
    Applicant: Apple Inc.
    Inventors: Dallas B. De Atley, Bailey E. Basile, Venkat V. Memula, Thomas P. Mensch, Robert M. Marini, David P. Remahl, Kelsey J. Skillman, Edward E. Thomas
  • Publication number: 20230181648
    Abstract: The present disclosure provides compositions and methods for the treatment or prophylaxis of a perfusion disorder, such as ischemia and/or reperfusion injury, in a subject's organ, tissue or extremity by preserving or improving endothelial function, reducing vascular injury, and/or promoting vascular repair. The disclosed compositions comprise endothelial colony-forming cells or a serum-free composition comprising chemically defined media conditioned by endothelial colony-forming cells.
    Type: Application
    Filed: September 2, 2022
    Publication date: June 15, 2023
    Inventors: Mervin C. Yoder, David P. Basile
  • Publication number: 20210338630
    Abstract: Disclosed are methods to treat a renal disorder in a mammal in need thereof by administering to the mammal in need of treatment an effective amount of a store operated calcium entry (SOCE) inhibitor or a pharmaceutically acceptable salt thereof.
    Type: Application
    Filed: October 4, 2019
    Publication date: November 4, 2021
    Applicant: The Trustees of Indiana University
    Inventors: David P. Basile, Purvi Mehrotra, Michael S. Sturek
  • Publication number: 20190388477
    Abstract: The present disclosure provides compositions and methods for the treatment or prophylaxis of a perfusion disorder, such as ischemia and/or reperfusion injury, in a subject's organ, tissue or extremity by preserving or improving endothelial function, reducing vascular injury, and/or promoting vascular repair. The disclosed compositions comprise endothelial colony-forming cells or a serum-free composition comprising chemically defined media conditioned by endothelial colony-forming cells.
    Type: Application
    Filed: February 21, 2018
    Publication date: December 26, 2019
    Applicant: Indiana University Research and Technology Corporation
    Inventors: Mervin C. Yoder, David P. Basile